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INORGANIC PHOSPHATE (P I ) IS an essential anion that is required for a wide variety of molecular and cellular processes. In mammals, the concentration of P i in plasma remains within a relative tightly controlled range (0.8 -1.4 mM in humans). This control is executed by organs responsible for P i absorption/ excretion (intestine and kidneys), P i storage (bones), as well as production and secretion of regulatory factors (kidneys, bones, and parathyroid glands; for a review, see Ref. 5) . However, the final control of P i homeostasis depends on the kidneys as they can adjust the urinary excretion of the anion to the body's specific requirements. The importance of the kidney in this process is highlighted by the deleterious consequences of both renal wasting and retention of the anion. Thus renal loss of P i leads primarily to skeletal deformities whereas hyperphosphatemia is implicated in vascular calcification and mortality in end-stage kidney disease (for a review, see Ref. 2) . The renal epithelia express at least three Na-dependent P i cotransporters: NaPi-IIa/SLC34A1, NaPi-IIc/SLC34A3, and PiT2/SLC20A2 (for a review, see Ref. 14) . These cotransporters are expressed in the brush-border membrane (BBM) of the proximal tubule, the major site for renal handling of P i along the nephron. We will use the SLC nomenclature when referring to the gene and the NaPi/PiT nomenclature to refer to the corresponding protein.
Regulation of P i homeostasis is achieved in part by the concerted action of factors produced by a recently identified parathyroid-bone-kidney axis: parathyroid hormone (PTH), fibroblast growth factor 23 (FGF-23), and 1,25-dihydroxyvitamin D [1, 25(OH) 2 D 3 ] (for a review, see Ref. 5) . The body responds to hyperphosphatemia by increasing the levels of PTH and FGF-23 (9, 22, 33, 34) . PTH and FGF-23 then target the kidney to elicit a phosphaturic response, thus contributing to the restoration of normal levels of P i in the blood (1, 18) . The increase in renal excretion of P i induced by both hormones is mediated by the removal of NaPi-IIa (faster response) and NaPi-IIc (slower response) from the proximal microvilli (17, 20, 25, 31) . PTH and FGF-23 also regulate, and are regulated, by the renal production of 1,25(OH) 2 D 3 (10, 11, 13, 32) . 1,25(OH) 2 D 3 stimulates the intestinal absorption of P i by increasing the expression of NaPi-IIb/SLC34A2 (15) . FGF-23 also seems to reduce the circulating levels of PTH (4) .
Several approaches have been applied to address the relative contribution of individual Na-P i cotransporters to the reabsorption of P i in the murine kidney. Thus microinjection of oocytes from Xenopus laevis with mRNA subjected to RNase H-mediated hybrid depletion suggested that NaPi-IIa mediates most of the Na-P i cotransport in kidneys from adult mice, with minimal or no contribution of NaPi-IIc (29) . NaPi-IIa also seems to be the major cotransporter in young mice, although the contribution of NaPi-IIc is higher in weaning than adult kidneys (29, 35) . A preponderant role for NaPi-IIa was also indicated in a study where the transport properties of renal BBM, as well as of oocytes injected with mRNAs for single cotransporters, were analyzed in response to pharmacological inhibitors and pH changes (43) . In addition to these indirect approaches, constitutive depletion of Slc43a1/NaPi-IIa in mice results in hypophosphatemia associated with renal P i wasting (3), even though the expression of NaPi-IIc in the proximal microvilli is upregulated (37) . PTH and FGF-23 are reduced in Slc43a1/NaPi-IIa-deficient mice, whereas 1,25(OH) 2 D 3 is increased, resulting in high circulating and urinary Ca 2ϩ (3, 38) . In contrast, the constitutive depletion of Slc34a3/NaPi-IIc does not lead to either hypophosphatemia or hyperphosphaturia, although mutant mice exhibit elevated 1,25(OH) 2 D 3 associated with hypercalcemia and hypercalciuria (30) . Together, these studies indicate that in mice NaPi-IIa mediates the bulk of renal reabsorption of P i whereas the contribution of NaPi-IIc is minimal and seems restricted to the young kidney.
In humans, mutations in several regulatory proteins that result in reduced expression of NaPi-IIa cause various hypophosphatemic syndromes. Mutations in the phosphate-regulating gene with homologies to endopeptidase in the X-chromosome (PHEX), FGF23, dentin matrix acidic phosphoprotein 1 (DMP1), and the ␣-subunit of stimulatory G protein (GNAS) were identified as the cause for hypophosphatemia in X-linked hypophosphatemic rickets (XLH), autosomal dominant hypophosphatemic rickets (ADHR), autosomal recessive hypophosphatemic rickets (ARHR), and fibrous dysplasia of bone and MAS, respectively (for a review, see Ref.
2). However, reports describing SLC34A1 gene variants are scarce, and their interpretation has remained controversial (27, 44) . Recently, mutations in SLC34A1 were reported in two siblings with autosomal recessive Fanconi disease (ARFD) and severe renal P i wasting (21) . In contrast, since the first three reports in 2006 (6, 16, 19) , many publications have clearly established that mutations in SLC34A3 cause hereditary hypophosphatemic rickets with hypercalciuria (HHRH).
Here, we report that the removal of Slc34a3 from kidneys of young mice does not impair P i homeostasis and renal P i handling. Instead, and in agreement with the constitutive depletion, all the P i -related parameters analyzed were undistinguishable in wild-type and Slc34a3-deficient mice. However, and unlike the constitutive mutants, the kidney-specific depletion of Slc34a3 does not alter Ca 2ϩ homeostasis. These observations suggest first that, unlike in humans, NaPi-IIc is not an essential Na-P i cotransporter in murine kidneys, and second that inactivation of the cotransporter in tissues other than kidney may be responsible for the disturbed Ca 2ϩ metabolism observed in patients with HHRH.
MATERIALS AND METHODS

Generation of renal-specific and inducible Slc34a3 knockout mice.
A conditional Slc34a3 allele was first generated by homologous recombination between the genomic DNA of embryonic stem cells (ESC) and the targeting vector shown in Fig. 1A . This vector consisted of a 2.3-kb fragment corresponding to the Slc34a3 genomic sequence located between introns 3 and 12, flanked by two loxP sites. This Fig. 1 . Generation of renal-specific and inducible Slc34a3 knockout mice. A: structure of the Slc34a3 gene (top), targeting vector (middle), and floxed allele (bottom). The gene consists of 13 exons (E), with the codon for the starting methionine (*) in exon 2 and the stop codon (*) at the end of exon 13. The targeting vector contained loxP sites (shaded triangles) within introns 3 and 12, a neo cassette (PGK-neo) flanked by FRT sites (black ellipses) just upstream of the 5=-loxP site, and the herpes simplex virus thymidine kinase (HSV-TK) at the very 3=-end of the construct. Upon proper homologous recombination in ESC, the wild-type (WT) gene was replaced by the floxed allele. The lanes at the bottom of the floxed allele indicate the position of the probes used for Southern blotting, whereas the location of the KpnI (K) and EcoRI sites (R) are indicated at the top. The first KpnI and the last EcoRI sites are located outside the Slc34A3 gene. Primers used to confirm the presence of loxP sites by PCR are also indicated. B: genomic DNA isolated from 4 clones of ESC surviving in the presence of neomycin but not ganciclovir as well as from one sample of untransfected cells was digested with either KpnI (K) or EcoRI (R) and tested for proper 5= and 3= recombination, respectively, by Southern blotting (top). The presence of the 5=-and 3=-loxP sites in the same DNA samples was confirmed by PCR (bottom). C: structure of the conditional allele indicating the location of the primers used to discriminate between WT (Slc34a3 ϩ/ϩ ), conditional heterozygous (Slc34a3 f/ϩ ), or conditional homozygous mice (Slc34a3 f/f ). D: structure of the gene upon doxycycline (Doxy)-induced removal of the floxed-sequence (top) and proposed Na-Pi cotransporter NaPi-IIc topology (bottom): only the intracellular N terminus would be expressed in mutant mice. fragment encodes residues 58 -447 of the NaPi-IIc transporter. To allow for homologous recombination, 5= and 3= homologous arms of ϳ1.9 Kb were placed outside of the loxP-flanked sequence (Fig. 1A) . For positive selection of ESC, the neomycin resistance gene driven by the phosphoglycerate kinase (PGK) promoter was inserted between the 5= homologous arm and the 5=-loxP site; this PGK-neo cassette was flanked by two frt sites. For negative selection, the thymidine kinase gene from herpes simplex virus (HSV-TK) was inserted downstream of the 3= homologous arm. After linearization with PacI, which cuts upstream of the 5= homologous arm, the DNA was transfected by electroporation into 129SV ESC. Clones able to survive in G418 but not in ganciclovir were further analyzed for homologous recombination by Southern blotting using two different probes: the probe used to test 5=-recombination (a) consisted of the last 700 bp of the 5= homologous arm, whereas the probe to test 3=-recombination (b) contained 550 bp located on the middle of the 3= arm (Fig. 1, A and  B) . Briefly, genomic DNA isolated from four selected clones as well as from untransfected ESC was digested with KpnI or EcoRI, separated in agarose gels, and transferred to nitrocellulose membranes. The membranes were hybridized with the 32 P-labeled probes according to standard procedures (Fig. 1B) . In addition, the presence of both loxP sites on the same DNA samples was confirmed by PCR ( Fig. 1,  A and B) . The 5=-loxP was detected with a sense primer that anneals partially to the loxP sequence (S1: CTTCGTATAGCATACAT-TATAC) and an antisense primer annealing to intron 12 (AS1: GCATGAGATGACCACAGG), whereas the 3=-loxP reaction was performed with a sense primer located within intron 3 (S2: GGAGATCCTGTGCTCTG) and an antisense primer annealing to the loxP sequence (AS2: CTTCGTATAATGTATGCTATAC) (Fig. 1, A  and B) . Upon confirmation of homologous recombination, one recombinant clone was microinjected into blastocysts derived from C57BL/6 mice. The blastocysts were implanted into NMRI pseudopregnant females producing chimera offspring. Transfection of ESC as well as blastocyst injection and implantation were done in collaboration with Dr. E. Hummler (Transgenic Animal Facility of the University of Lausanne), as described (26) . Mice heterozygous for the transgene were bred with 64FlpeB6 mice to remove the neo-cassette. Homozygous floxed Slc34a3 in which the neo-cassette was removed from the transgene were breed with Pax8-rtTA/LC1 double transgenic mice (39) . In this transgenic model, the expression of Cre-recombinase is induced by doxycycline (Doxy) in a kidney-restricted manner. Further crossbreeding resulted in the generation of wild-type (Slc34a3 ϩ/ϩ ), conditional heterozygous (Slc34a3 f/ϩ ), and conditional homozygous mice (Slc34a3 f/f ) positive for both Pax8-rtTA and Cre (Fig. 1C) . Genotyping was performed by PCR using as a template genomic DNA isolated from ear biopsies. Genotyping of Slc34a3 was done with a sense primer annealing within exon 3 (GAAGAACGCT-GACCAACTG) and an antisense primer that anneals in exon 4 (CTCACTGCCTAGTAGCTG) (Fig. 1C) , whereas the presence of Cre and Pax8-rtTA was analyzed with the primers described in the original manuscript (39) . Renal-specific removal of the loxP-flanked sequence by Cre-recombinase should result in a truncated mRNA containing exons 1-3 and potentially exon 13 ( Fig. 1D) .
Animal handling and sample collection. Animal handling complied with the Swiss Animal Welfare laws, and the experimental protocols were previously approved by the local veterinary authority (Kantonales Veterinäramt Zürich). Expression of Cre-recombinase was induced in both genders and three genotypes by providing Doxy in the drinking water sweetened with 2% sucrose, whereas the controls drank 2% sucrose without the antibiotic. Doxy was prepared freshly every 2 days and was protected from light by wrapping the bottles with black plastic. Treatments were initiated immediately after weaning. Animals were always fed with standard diet (KLIBA, SA) containing 0.8% Pi. Three days before the end of the induction protocol, mice were placed in individual metabolic cages, having free access to food and liquid (Doxy, sucrose, or water). After 2 days of adaptation to the new housing conditions, 24-h urine was collected under mineral oil. Mice were then anesthetized with a mixture of ketamine and xylazine, and blood, kidneys, and ileum mucosa were extracted and immediately frozen.
Real-time RT-PCR. The renal expression of several mRNAs was quantified by real-time RT-PCR. In brief, half kidneys were homogenized in RLT buffer, and total RNA was extracted using an RNeasy Mini Kit (Qiagen). This RNA was incubated with reverse transcriptase (TaqMan Reverse Transcription Kit, Applied Biosystems), and the generated cDNA was then used as a template for real-Time PCR. Quantification of NaPi-IIc mRNA was performed with a set of primers and TAMRA-probe that anneal to the sequence of the mRNA that should be missing upon removal of the floxed-fragment. The sense primer (CAGCGGTATTACCAGCAACA) anneals to exon 8, whereas both the antisense primer (CTGTCCTCCTCTGGAGATGC) and the probe (GTGGCCTCTTCAGCTCTTGCACAGA) anneal to exon 9. The expressions of 1␣-hydroxylase/CYP27B1, 24-hydroxylase/CYP24A1, and hypoxanthine guanine phosphoribosyl transferase (HPRT) were quantified using commercial primers and probes (Taqman Gene Expression Assays). PCRs were performed with the TaqMan Universal PCR Master Mix. The expression of the genes of interest was normalized to the expression of HPRT by applying the formula R ϭ 2
[Ct(HPRT) ϪC t(test gene)] , where R is the relative ratio and Ct indicates the cycle number at the threshold of 0.2.
Western blots. Whole kidneys and ileum mucosa were homogenized in a buffer containing (in mM) 300 mannitol, 5 EGTA, and 12 Tris·HCl, pH 7.1. BBMs were then prepared according to the Mg 2ϩ precipitation procedure (7) . Upon quantification of protein concentrations (Bio-Rad protein determination kit), BBMs (15 g) were separated on 9% SDS/PAGE gels and transferred to PVDF membranes (Millipore). Membranes were then incubated overnight with antibodies against NaPi-IIa (12), NaPi-IIc (24), NaPi-IIb (15), PiT2 (40) , and ␤-actin (Sigma). After incubation with the appropriate secondary antibody (GE Healthcare) and chemiluminescent substrate (Millipore), the protein-related signals were detected on a LAS-4000 luminescent image analyzer (Fujifilm). Signals were quantified with the Advanced Image Data Analyzer (Raytest). ␤-Actin was used as a loading control.
Immunofluorescence. Immunofluoresence of renal sections was performed according to standard procedures. Doxy-treated mice (Slc34a3 ϩ/ϩ and Slc34a3 f/f ) were perfused with 3% phosphonoformic acid (PFA) in 0.1 M sodium cacodylate, upon which the kidneys were extracted and frozen in embedding medium (Dako) using liquid propane. Cryosections (5 m thick) were prepared with a Leica microtome. Upon blocking of unspecific binding sites (1% BSA in PBS, 1 h at room temperature), samples were incubated overnight at 4°C with primary antibodies diluted in blocking buffer (1:1,000 NaPi-IIa, 1:500 NaPi-IIc). Alexa 594 anti-rabbit secondary antibody (Invitrogen) together with Alexa 488-coupled phalloidin (Life Technologies) was applied next morning (1 h at room temperature). Immunofluorescence signals were analyzed with an epifluorescence microscope (Leica).
Uptakes of 32 P and D-[ 3 H]glucose into renal brush-border membrane vesicles. Uptakes of
32 P into brush-border membrane vesicles (BBMV) were performed according to the filtration technique as already described (36) . In brief, aliquots of vesicles were incubated for 1 min in three different solutions: 0 mM Na ϩ , 100 mM Na ϩ , and 100 mM Na ϩ plus 6 mM PFA. All solutions contained 0.1 mM H2PO4K and 32 P as a tracer. Incorporation of 32 P into the BBMV was measured in a ␤-counter (Packard). The uptake of 32 P detected in the presence of Na ϩ reflects the total Pi uptake, i.e., the transport mediated by Na ϩ -dependent and -independent processes. The Na ϩ -dependent uptake was calculated by subtracting the values obtained in the absence of Na ϩ (Na ϩ independent) from those in the presence of Na ϩ (total uptake). The SLC34-mediated component of the Na ϩ -dependent uptake was calculated by subtracting the values measured in the presence of Na ϩ plus PFA from those obtained in the presence of Na ϩ without the inhibitor, whereas the SLC34-independent component was calculated by subtracting the values in the absence of Na ϩ from those obtained in the presence of Na ϩ plus PFA. For the determination of the uptake of were analyzed by ion chromatography (Metrohm 820 Professional IC). Renal excretion of ions was normalized to creatinine that was quantified according to the Jaffé method (Wako Chemical).
The concentrations of 1-84 PTH and FGF23 in plasma were evaluated with ELISA kits (Immunotopics), whereas the concentration of 1,25(OH) 2D3 was quantified by radioimmunoassay (Immunodiagnosticsystem). In all three cases, we followed the instructions recommended by the manufacturers.
Statistical analysis. One-way ANOVA was applied to analyze differences between groups, except for experiments presented in Figs. 4 and 7, in which a t-test was applied. Differences with P Ͻ 0.05 were considered significant.
RESULTS AND DISCUSSION
Generation of renal-specific and inducible Slc34a3 knockout mice. To generate the renal-specific and inducible Slc34a3 knockout model, we first produced floxed-Slc34a3 transgenic mice in which the genomic sequence contained between introns 3 and 12 was replaced by the sequence of the vector shown in Fig. 1 (Fig. 1, A-D) . Upon breeding with 64FlpeB6 mice to remove the neo-cassette from the floxed gene, animals were further bred with Pax8-rtTA/LC1 double transgenic mice (39) . In this second transgenic model, the Pax8 promoter drives the expression of the reverse tetracycline-dependent transactivator (rtTA). The rtTA in the presence of Doxy transactivates the tetracycline-responsive element (TRE), a bidirectional P tet that in these mice controls the expression of luciferase (L) and Cre-recombinase (C). It was shown that treatment with Doxy of Pax8-rtTA/NZL-2 mice, a transgenic line that contains and Slc34a3 f/f mice drinking either sucrose (S) or 2 mg/ml Doxy (D). C: urinary excretion of Na ϩ in Slc34a3 ϩ/ϩ mice drinking the indicated concentrations of Doxy. The renal expression of NaPiIIc mRNA was normalized to the expression of HPRT, and it is given as means Ϯ SE. The urinary concentration of Na ϩ (mM) was corrected by the excretion of creatinine (mg/dl), and in C it is presented as a percentage of change compared with the sucrose group Ϯ SE; n ϭ at least 6 mice/group. *P Յ 0.05, **P Յ 0.005, ***P Յ 0.001, ANOVA. Fig. 3 . Expression of Slc34a3 mRNA upon administration of Doxy. The expression of NaPi-IIc mRNA was analyzed in total RNA samples extracted from kidneys of males (A) and females (B) drinking either 0.5ϩ0.25 mg/ml Doxy in 2% sucrose (D) or sucrose alone (S). The expression of NaPi-IIc mRNA was normalized to the one of HPRT. Values are means Ϯ SE; n ϭ at least 6 mice/group. *P Յ 0.05, ***P Յ 0.001, ANOVA.
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␤-galactosidase instead of Cre-recombinase, leads to reporter activation only in the renal tubular epithelia and some periportal hepatocytes (39) . In our model, induction of Cre in hepatocytes should not be a confounding factor, as the expression of NaPi-IIc mRNA in the liver is, if any, far smaller than in the kidney (23, 29) . Further crossbreeding produced wild-type (Slc34a3 ϩ/ϩ ), conditional heterozygous (Slc34a3 f/ϩ ), and conditional homozygous mice (Slc34a3 f/f ) positive for both Pax8-rtTA and Cre (Fig. 1C) . Expression of Cre was induced in both genders and three genotypes by providing Doxy in the drinking water. As murine NaPi-IIc is mostly expressed in juvenile animals and its levels decrease in adults, the Doxy treatment was initiated immediately after weaning (ϳ3 wk after birth). Doxy-induced activation of Cre-recombinase should result in the removal of the loxP-flanked sequence and therefore a truncated mRNA only consisting of exons 1-3 and exon 13, assuming that splicing still takes place (Fig. 1D) . The potential splicing between exon 3 and 13 would result in a frame shift containing a stop codon after 58 (NaPi-IIc-unrelated) residues. Thus this truncated mRNA would encode only for the first 57 amino acids of the cotransporter that constitute the intracellular N-terminus (Fig. 1D) .
Expression of Cre-recombinase was induced initially by supplementing the drinking water with 2 mg/ml Doxy and 2% sucrose. As a negative control, the corresponding littermates received water supplemented only with 2% sucrose. Both treatments were administered for 10 days. Based on quantitative PCR analysis, this protocol resulted in almost complete depletion of NaPi-IIc mRNA in kidneys of male Slc34a3 f/f mice drinking Doxy compared with their sucrose controls ( Fig. 2A) , indicating an optimal efficiency of the Cre-induction protocol. However, the urinary excretion of several cations was altered in mice receiving Doxy. As shown in Fig. 2B , the administration of 2 mg/ml Doxy reduced the excretion of Na ϩ to one-third compared with sucrose controls. This reduction was identical in conditional homozygous (Slc34a3 f/f ) and in wildtype (Slc34a3 ϩ/ϩ ) groups. In addition, the treatment with Doxy increased the excretion of Ca 2ϩ (data not shown), and this change was also identical in Slc34a3 ϩ/ϩ Slc34a3 f/f . Although we do not know whether these alterations are due to a direct effect of the antibiotic on the kidney or are secondary to intestinal changes, they are clearly unrelated to the depletion of the cotransporter.
To determine the concentration of Doxy able to efficiently deplete the kidney of NaPi-IIc mRNA without causing nonspecific changes in urinary values, several concentrations of the antibiotic (1, 0.5, and 0.25 mg/ml) were administered for 10 days to Slc34a3 f/f and Slc34a3 ϩ/ϩ males; the treatment was followed by a recovery period of 15 days, during which the mice drank normal tap water. Then, we quantified the expression of NaPi-IIc mRNA in kidneys from Slc34a3 f/f mice, whereas the excretion of Na ϩ was measured in urine collected from Slc34a3 ϩ/ϩ animals. Administration of 1 and 0.5 mg/ml Doxy to Slc34a3 f/f mice resulted in almost complete depletion of NaPi-IIc mRNA, whereas depletion was only ϳ75% in the kidneys of mice drinking 0.25 mg/ml Doxy (Fig. 2A) . The excretion of Na ϩ in wild-type (Slc34a3
) was used as an indicator for nonspecific effects of the antibiotic, as it was the cation that showed the highest changes in the Doxy-drinking groups. As shown in Fig. 2C , the urinary excretion of Na ϩ was still reduced in Slc34a3 ϩ/ϩ mice drinking 1 and 0.5 mg/ml Doxy, whereas 0.25 mg/ml was without effect. Therefore, the three concentrations of Doxy able to fully deplete the kidneys of NaPi-IIc mRNA in Slc34a3 f/f also altered the excretion of Na ϩ in Slc34a3
, whereas normal Na ϩ urinary values were only observed with the concentration of antibiotic that only partially downregulated gene expression. Based on these findings and on the fact that the levels of NaPi-IIc decrease with age, which restrains the total duration of the induction procedure, a final experimental protocol was defined. The induction was initiated in 3-wk-old mice and consisted of the administration of 0.5 mg/ml Doxy for 5 days followed by 5 days with 0.25 mg/ml Doxy. After these 10 days with the antibiotic, animals were left to recover for 15 additional days, during which they drank normal tap water. Therefore, by the termination of the experiment and sample collection, the mice were 6 -7 wk old. Quantification of the urinary excretion of Na ϩ indicated no differences between the sucrose-and Doxytreated groups by the end of the experiment (data not shown).
Knockdown of Slc34a3 upon administration of Doxy. As shown in Fig. 3 , administration of 0.5ϩ0.25 mg/ml Doxy did not alter the expression of NaPi-IIc mRNA in kidneys from Slc34a3 ϩ/ϩ mice whereas it resulted in ϳ50% reduction in Slc34a3 f/ϩ animals and 85% loss in Slc34a3 f/f . Similar effects were found in both males (Fig. 3A) and females (Fig. 3B) . The changes in mRNA expression were paralleled by changes in the amount of the protein expressed in the renal BBM. Thus quantification of the expression of NaPi-IIc normalized to actin indicates that the Doxy treatment did not alter the abundance of NaPi-IIc in renal BBM from Slc34a3 ϩ/ϩ mice but lead to ϳ50 and 90% reduction in Slc34a3 f/ϩ and Slc34a3 f/f animals, respectively. As for the mRNA levels, similar changes were observed in males (Fig. 4, A and B) and females (Fig. 4, C and  D) . Of note, the interanimal heterogeneity observed for the expression of the cotransporter in BBM does not seem to be related to protein degradation as the levels of NaPi-IIa detected in the same samples were relatively homogenous (see Fig. 7A ). The absence of NaPi-IIc in the renal BBM of Slc34a3 f/f mice drinking Doxy was further confirmed by immunofluorescence. As shown in Fig. 5 , both NaPi-IIa (Fig. 5A) and NaPi-IIc (Fig. 5B) were detected in the lumen of proximal tubules of Slc34a3 ϩ/ϩ mice drinking Doxy. However, this treatment resulted in depletion of NaPi-IIc from the kidneys of Slc34a3 f/f animals. Together, these findings indicate that the final Cre-induction protocol resulted in almost complete depletion of the cotransporter from the renal BBM of Slc34a3 f/f mice without displaying nonspecific changes.
NaPi-IIa Actin
Effect of Slc34a3 knockdown on the uptake of P i into renal BBMV. Renal reabsorption of P i is an active process that takes place predominantly along the proximal tubule. The BBM of murine proximal tubular cells expresses at last three Na ϩ -P i cotransporters, NaPi-IIa, NaPi-IIc, and PiT2 (for a review, see Ref. 14) . To study the contribution of NaPi-IIc to the proximal reabsorption of P i , we compared the uptake of 32 P into renal BBMV from wild-type and renal-specific Slc34a3 knockouts. Uptake was determined in three different media: in the absence or presence of Na ϩ , with PFA, or without PFA (a Slc34 inhibitor) in the latest. This allowed us to calculate, in addition to the total and the Na ϩ -dependent P i uptakes, the Slc34-dependent and -independent components of Na ϩ -dependent P i transport. As shown in Fig. 6A , the absence of NaPi-IIc did not result in changes in total P i uptake (i.e., the transport of P i into BBMV mediated by Na ϩ -dependent and -independent processes), as all values were similar regardless of the genotype (Slc3aA3 ϩ/ϩ vs. Slc34a3
) or drinking protocol (sucrose alone vs. Doxy). The Na ϩ -dependent component represents up to 99% of the total uptake of P i into renal BBMV and reflects the activity of both Slc34 and Slc20 cotransporters. Figure 6B shows that Na ϩ -dependent P i uptake remained unaffected upon removal of NaPi-IIc from the renal BBM. This finding is in agreement with previous data demonstrating that the constitutive removal of NaPi-IIc does not alter the Na ϩ -dependent P i uptake in renal BBMV from 9-wk-old mice (30) . Moreover, the absence of NaPi-IIc in Slc34a3 f/f mice drinking Doxy did not reduce the contribution of the Slc34-dependent (Fig. 6C) or Slc34-independent components (Fig. 6D) . As a negative control, the uptake of glucose was measured in parallel. Figure 6E shows that this uptake was comparable in all groups of animals. Taken together, our data indicate that similar to the constitutive knockout, the renal-specific ablation of Slc34a3 in weaning mice does not alter the capacity of the proximal BBM to transport P i , suggesting a neglectable contribution of this cotransporter to renal reabsorption of P i in mice.
Effect of Slc34a3 knockdown on the expression of other Na-dependent P i cotransporters. The uptake experiments described above cannot discriminate between the transport mediated by NaPi-IIc and NaPi-IIa, since both proteins are inhibited by PFA (42) . Theoretically, the absence of NaPi-IIc in the proximal BBM could be compensated by increased expression of NaPi-IIa. Similarly, the abundance of NaPi-IIc is increased in mice lacking NaPi-IIa, although such upregulation is not able to prevent the urinary loss of P i , and NaPi-IIa-deficient mice are hypophosphatemic (3, 37) . Similar compensatory f/f males treated with sucrose (white bars) or Doxy (grey bars) was measured after 1-min incubation in media containing 0 mM Na ϩ , 100 mM Na ϩ , and 100 mM Na ϩ plus 6 mM phosphonoformic acid (PFA) A: total Pi uptake corresponds to the uptake of 32 P measured in the presence of Na ϩ ; it reflects the transport of Pi into BBMV mediated by Na ϩ -dependent and -independent processes. B: Na ϩ -dependent Pi uptake was calculated by subtracting the uptakes obtained in the absence of Na ϩ (Na ϩ -independent) from those in the presence of Na ϩ . C: Slc34-dependent Pi uptake was calculated by subtracting the uptakes measured in the presence of Na ϩ plus PFA from the values obtained in the presence of Na ϩ without the inhibitor. D: Slc34-independent Pi uptake was calculated by subtracting the uptakes measured in the absence of Na ϩ from those obtained in the presence of Na ϩ plus PFA. E: total D-glucose uptake corresponds to the uptake of D-[ 3 H]glucose measured in the presence of Na ϩ ; n ϭ 7-8 animals/group. No statistically significant differences were observed (ANOVA). mechanisms among P i transporters have also been reported in mice lacking NaPi-IIb, a protein involved in the active absorption of P i in the small intestine (28): despite losing P i through the feces, these animals have normal values of P i in plasma as a consequence of a compensatory increase in renal retention achieved by upregulation of NaPi-IIa. However, and as reported for the constitutive Slc34a3 knockout (30), we found that the amount of NaPi-IIa detected in renal BBM was similar in the Doxy and sucrose groups, in both males (Fig. 7, A and B) and females (data not shown). From the two Slc20 cotransporters, PiT2 is expressed in the proximal BBM in murine kidneys (41) . The contribution of the Slc20 family to renal handling of P i seems rather small. Still, the expression of PiT2 responds to dietary changes in P i as well as PTH, suggesting a potential regulatory role of this transporter (41) . However, the expression of PiT2 was not altered in renal BBM from Slc34a3 f/f mice drinking Doxy compared with the sucrose-drinking controls (Fig. 7, C and D) . Therefore, the absence of changes in the P i transport capacity in NaPi-IIc-depleted mice cannot be explained by a compensatory upregulation of NaPi-IIa or PiT2. In agreement with the lack of changes in the expression of renal cotransporters, the abundance of NaPi-IIb in the ileum was similar in all groups of mice (Fig. 7, E and F) .
Effect of Slc34a3 knockdown on P i and phosphaturic hormones. In agreement with the similar P i transport capacity of the renal BBM, also the urinary excretion of P i (Fig. 8A) as well as the concentration of P i in plasma (Fig. 8B) were comparable in all groups of mice. Both parameters also remained unchanged in Slc34a3 constitutive knockouts (30) whereas circulating P i is reduced and urinary P i is increased in mice constitutively depleted of Slc34a1 (3).
PTH and FGF23 are two major regulators of renal reabsorption of P i . Their levels increase in response to hyperphosphatemia/phosphate loading and drop under conditions that require P i retention (for a review see Ref. 5) . Both PTH and FGF23 are downregulated in Slc34a1-deficient mice, consistent with the reduced plasma levels of P i in these animals (3, 38) , whereas FGF23 but not PTH is reduced in Slc34a3 constitutive knockouts (30) . Consistently with the absence of changes in the expression of NaPi-IIa in renal BBM, we found that both PTH (Fig. 8C) as well as FGF23 (Fig. 8D ) remained unchanged in Slc34a3 f/f mice drinking Doxy compared with the sucrose-drinking controls. PTH values showed a high degree of intragroup variability. We reported recently that the levels of this hormone change very quickly in response to switches in dietary P i (8) . At the end of the sucrose/Doxydrinking protocol, animals were housed in single metabolic cages and food intake was closely monitored. Although the food intake was similar in all groups, we cannot estimate when the latest feeding time took place. Therefore, a potential explanation for the PTH variability could be different feeding behaviors among animals.
Together, our data indicate that the renal-specific ablation of Slc34a3 in weaning mice does not affect P i homeostasis, as none of parameters determined was changed upon removal of the cotransporter. With the exception of FGF23, which levels were reduced in the constitutive knockouts (30), our findings are in agreement with the data published by Segawa et al. supporting the notion that unlike in humans, NaPi-IIc is not required for the control of P i -homeostasis in mice.
Effect (15) . The higher 1,25(OH) 2 D 3 reported in constitutive Slc34a3-deficient mice is likely due to reduced catabolism rather than increased production, as the mRNA levels of 24-hydroxylase are reduced whereas those of 1␣-hydroxylase remain unchanged in mutant mice (30) . In addition to the mouse model, mutations of SLC34A3 in humans lead not only to hypophosphatemia but also to hypercal- ciuria, secondary to high levels of 1,25(OH) 2 D 3 (6, 16, 19) . Interestingly, the urinary and circulating levels of Ca 2ϩ remained normal in Slc34a3 f/f mice drinking Doxy (Fig. 9, A and B) . Moreover, the concentration of 1,25(OH) 2 D 3 in plasma did not change upon removal of NaPi-IIc (Fig. 9C) . This later finding is in agreement with the observation that the renal expression of the mRNAs of both 1␣-hydroxylase (Cyp27b1) and 24-hydroxylase (Cyp24a1) were also similar in all groups (Fig.  9D) . Thus also the Ca 2ϩ metabolism parameters remain unchanged in our Slc34a3-deficient mice. The differences between the constitutive model and the one reported here are twofold: constitutive vs. inducible and kidney-specific vs. ubiquitous ablation. Studies addressing the tissue distribution of NaPi-IIc at the protein level are scarce. In the original paper describing the cloning of NaPi-IIc, the expression of the cotransporter mRNA in several human and rat tissues was analyzed by Northern blotting (29) . In both species, mRNA was only detected in the kidney. More recently, the pattern of expression of all SLC transporters was analyzed in 28 human tissues by quantitative PCR (23) . Whereas the highest abundance of NaPi-IIc mRNA was confirmed in the kidney, the cotransporter transcript was detected in basically every tissue analyzed, with the next higher levels (ϳ10 times lower than in the kidney) corresponding to the ovary, testis, and spinal cord. This opens the possibility that the effect of NaPi-IIc on Ca 2ϩ metabolism may be mediated by its expression in tissues other than the kidney and highlights the need for a thorough analysis of the tissue distribution of the cotransporter not only at the mRNA but also at the protein level. In this context, and given the increasing generation of tissue-specific Cre lines, our Slc34a3-floxed model may prove helpful in further investigating the implication of NaPi-IIc in controlling the homeostasis of Ca 2ϩ . In summary, we have generated a renal-specific and inducible knockout model of NaPi-IIc/Slc34a3. Our findings are in agreement with previous studies showing that, unlike in humans, the absence of NaPi-IIc does not disturb the homeostasis of P i in mice. However, and unlike in the constitutive mutants, the renal-specific ablation of the cotransporter in weaning mice does not alter the homeostasis of Ca 2ϩ .
